Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for CIPN Prevention in Breast and Gynecological Cancers
NCT05689359Phase 2Withdrawn
- Sponsor
- University of Arizona
- Start
- Jun 2024
- Primary completion
- Feb 2025
01
Overview
A Phase 2 trial of hydroxychloroquine in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by University of Arizona. Planned start Jun 2024; status: withdrawn.
02
Drugs
hydroxychloroquine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT05689359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05689359.